| Home | E-Submission | Sitemap | Contact Us |  
J Epilepsy Res > Volume 0(0); > Article
Rajeswarie, Aravinda, Arivazhagan, Bevinahalli, Rao, and Mahadevan: Evaluating the Role of Perilesional Tissue in Pathobiology of Epileptogenesis of Vascular Malformations of the Central Nervous System

Abstract

Background and Purpose

Seizures are common presentation of cerebral vascular malformation (CVM). Topography and haemodynamic alterations are proposed as mechanisms for epileptogenesis, but the role of glial/neuronal alterations in perilesional tissue has not received much attention. Identification of the exact pathophysiologic basis could have therapeutic implications. To evaluate whether angioarchitectural factors of CVM or alterations in neuroglial/stroma of the adjacent cortex contribute to seizures.

Method

The clinical, imaging and histological characteristics of arteriovenous malformation (AVM) and cerebral cavernous malformation (CCM) with and without seizures was evaluated using neuroimaging imaging and digital subtraction angiography parameters and histopathology by morphology and immunohistochemistry.

Results

Fifty-six cases of CVM were diagnosed over a 2-year study period. Of these, 32 had adequate perilesional tissue for evaluation (AVM, 24; CCM, 8). Seizures at presentation was seen in 12/24 (50%) of AVM and 5/8 (62.5%) CCM. In AVM, hemosiderin deposition and gliosis in parenchyma (p=0.01) had significant association with seizure. Siderotic vessels in the adjacent cortex was exclusively seen only in CCM with seizures (p=0.018). Angioarchitectural features of CVM on imaging and neuronal alterations in adjacent cortex on histology failed to show any statistically significant difference between the two groups (p>0.05).

Conclusions

We propose that changes in adjacent cortex appear to be epileptogenic rather than the malformation per se. Reactive gliosis and hemosiderin deposits in perilesional tissue in AVM and siderotic vessels in CCM were associated with seizure. This explains the better outcomes following extended lesionectomy that includes epileptogenic perilesional tissues.

Introduction

Cerebral vascular malformations (CVMs) are of clinical importance because of their propensity to cause intracerebral hemorrhage (ICH) and/or seizures.1,2 Arteriovenous malformations (AVMs) and cerebral cavernous malformation (CCM) are the most frequent forms of CVMs. Epileptic seizures are a frequent manifestation of both AVM and CCM3 but its importance is often overlooked in favor of ICH, which is the most frequent and feared component of a CVM’s natural history.4 Seizures are however debilitating and adversely impact the quality of life.5 The incidence of seizures as presenting complaint in AVM and CCM is 30% and 47% respectively in hospital-based studies.2
Predisposing factors for seizures in AVM include male gender, younger age, temporal or frontal lobe location, AVM nidus diameter >3 cm, superficial or cortical location, middle cerebral artery feeders, absence of associated aneurysms, presence of a venous varix/varices, and superficial venous drainage.69 Similarly, in CCM, supratentorial location, cortical involvement, and, interestingly an archicortical/mesiotemporal localization is more frequently associated with seizures.1013
The exact pathomechanism inciting seizures in CVM remains uncertain. To explain the pathophysiology of epilepsy in patients with AVM, haemodynamic alterations, hemosiderin deposits and vascular remodeling of malformation have been implicated,9,14 while in CCM, a few studies have evaluated the angioarchitectural features of CVMs and their relationship with epileptic seizures.5,15 However, most studies have focused on the alterations in angioarchitecture, that is, the constituent vessels participating in the malformation, but not much attention has been focused on the changes in the perilesional tissue and adjacent cortex, particularly the neuronal and glial components that could directly contribute to seizure induction.
Insights into the specific histomorphological factors associated with seizures could aid in elucidating pathomechanism of epileptogenesis and play a role in predicting the surgical outcome.16 In this study, we evaluated angioarchitectural factors, alterations in perilesional tissue and neuroglial/stromal elements of the perilesional cortex in AVM and CCM to ascertain its contribution to seizures.

Methods

Patient selection criteria and cohort composition

We reviewed all cases diagnosed as AVM and CCM at the Department of Neuropathology, National Institute of Mental Health & Neurosciences, Bangalore, India over a 2 years period between 2015 and 2016. Institutional review board approval obtained. We included cases of AVM and CCM with and without seizures for comparison, as our primary aim was to decipher the angioarchitectural and histomorphological differences that underlie epileptogenesis.

Inclusion criteria

(1) Cerebral lobar lesions-we restricted to lobar lesions to eliminate selection bias, as the location of the lesion is a known risk factor associated with seizure and (2) cases which were subjected to surgical resection with adequate perilesional tissue and adjacent cortex for evaluation.

Exclusion criteria

(1) Midline, deep gray matter nuclei and brainstem lesions; (2) inadequate tissue for histopathological analysis; and (3) cases with prior surgery or embolization. Clinical, imaging and histological characteristics of patients with AVM and CCM with & without seizures were reviewed.

AVM-imaging assessment

The angioarchitecture of the AVM nidus/CCM was defined by a combination of magnetic resonance imaging (MRI) and digital subtraction angiography (DSA). For each AVM the angioarchitectural characteristics examined included: (1) location; (2) feeding artery-number (single/multiple), presence or absence of hypertrophy of the feeding artery (increase in the diameter of the vessel by more than 50%), feeding artery aneurysm, and steal phenomena; (3) nidus-size of the lesion (small <3 cm; medium 3–6 cm; large >6 cm) based on Spetzler-Martin grading scale,17 presence or absence of bleed, aneurysm/fistula (absence of intervening nidus between the artery and vein); (4) draining vein-number (single/multiple), length of leptomeningeal course of the vein (short <2 cm; medium 2–4 cm; long >4 cm) reference to be given, superficial or deep, presence or absence of aneurysm/stenosis; and (5) adjacent parenchyma-presence/absence of hemosiderin deposits, inflammation, gliosis.

CCM-imaging assessment

(1) Location, size of the lesion (<3 cm, 3–6 cm, and >6 cm), number-single/multiple; (2) type of CCM based on Zabramski classification on MRI;18 and (3) presence or absence of post contrast enhancement, perilesional hypointensity, blooming on gradient/susceptibility weighted imaging (SWI) images and gliosis.

Histopathology

Histological characteristics were evaluated using Hematoxylin and Eosin, masson trichrome stain for collagen, Perls Prussian blue stain for hemosiderin, Verhoff’s van gieson stain for elastic fibres. Indirect immunohistochemsitry was performed using GFAP (1:200, 6F2, Dako, Rockville, MD, USA), Neu N (1:500, A60, Merck Millipore, Temecula, CA, USA), phosphorylated neurofilament (phospho NF-1:200, 2F11, Dako). Angioarchitectural changes in vessels-sclerosis of the vessel, thrombosis, intraluminal calcification. In AVM, proportion of arterial, venous and arterialized veins were assessed. (1) Changes in perilesional tissue-hemosiderin deposits, gliosis, reactive astrocytosis, inflammation, calcification, infarction, fibrosis and side-rotic vessels. Siderotic vessels are perilesional thin walled blood vessels with hemosiderin deposition on the vessel wall; (2) Adjacent cortex-dyslamination and dysmorphic changes in neurons were studied using GFAP, Neu N, and Phospho NF respectively; (3) each parameter Rajeswarie RT, et al. Epileptogenesis in CNS Vascular was assessed as present or absent; and (4) gliosis was subjectively graded as mild, moderate or severe.

Statistical analysis

Statistical analysis was performed using SPSS version 18 (SPSS Inc., Chicago, IL, USA). Categorical variables were compared using chi-square test. p-value of less than 0.05 was considered statistically significant. Univariate logistic regression analysis was performed to identify the radiological and histomorphological features associated with seizure presentation.

Result

During the 2 years study period, 41 were diagnosed as AVM. Seizure was the initial presenting symptom in 16 (39%). There were 15 cases diagnosed as CCM during the same period, of which seven (46.6%) had seizures as the presenting complaint. Of these, 24 AVM and eight CCM had sufficient perilesional cortex to be included in the study.
We examined 24 patients with AVM, 18 male (75%) and six female (25%). The age at the time of diagnosis ranged from 14 years to 62 years (mean, 28.9 years). Initial clinical manifestations were seizure in 12 patients (50%), headache in eight (33.3%), focal neurological deficit in three (12.5%) and one patient was asymptomatic. We also examined eight patients with CCM, seven male and one female. The age at the time of diagnosis ranged from 18 years to 40 years (mean, 27.8 years). Initial clinical manifestations were seizure in five patients (62.5%).

AVM topographic and angioarchitectural features on radiology

The topographic and angio-architectural features of AVM on radiology are summarized in Table 1. Most patients were in the age range of 21–40 years (62.5%). Males were most commonly affected (75%). Frontal lobe was most common location (33.3%), followed by the temporal lobe (29.2%). No statistically significant difference was noted in demographic characteristics, or location between those with and without seizures. We had selected only those with lobar lesions to remove any confounding factor, as it is well established that superficial lobar lesions are commonly associated with seizure and our primary aim was to decipher the changes in these lesions and the adjacent parenchyma that cause epileptogenesis. The angioarchitectural features of 21 cases of AVM on both MRI and DSA were analyzed by univariate logistic regression, and none of the features were found to be significantly associated by seizure (Fig. 1A–C, J–L).

Histomorphological features of AVM

AVM revealed conglomerate of arteries, arterialised veins and veins in the nidus. The proportion of each component varied with arterial component predominating in 58%, venous in 42%. The vasculature of the vasoformative lesion revealed varying degrees of mural thickening, calcification, acquisition of elastic fibres in arterialized veins (Fig. 1D, E, M, N). The adjoining tissue revealed gliosis, inflammation, calcification, and infarction in event of steal phenomenon. Extent of hemorrhage varied with evidence of fresh and old bleed (Fig. 1F). We analyzed the histomorphological features of the lesion, perilesional tissue and the adjacent cortex in detail and compared findings between patients with and without seizures, summarised in Table 2 and Fig. 1.
We observed that hemosiderin deposition (Fig. 1F) and gliosis (Fig. 1I) of the perilesional tissue was more common in patients presenting with seizures compared to those without seizures (Fig. 1O, R) and the difference was statistically significant (p<0.05). No difference between the groups was found with other lesional/perilesional features like sclerosis of vessel, thrombosis, proportion of the AVM component, bleed, inflammation, fibrosis, infarction, calcification and cortical changes like dyslamination/dysmorphic changes in cortical neurons (Fig. 1G, H, P, Q).
Fig. 1 angioarchitectural features and changes in perilesional tissue of AVM with and without seizures on radiology and histomorphology.

CCM topographic and angioarchitectural features on radiology

The topographic and angioarchitectural features of CCM based on radiology is summarized in Table 3, Fig. 2 A–C, J–L). The age range was 21–40 years (75%). Males were more commonly affected (87.5%). Frontal lobe was most common site (62.5%), followed by temporal lobe (37.5%). Statistical analysis showed no significant differences between demographic characteristics, or angioarchitectural features between patients with or without seizures.

Histomorphological features of CCM

CCM were characterized by back to back arranged thin venous channels lined by flattened endothelium (Fig. 2D, E, M, N). No parenchymal insinuation was seen between the vessels. The vessels demonstrated varying degree of vascular sclerosis, calcification and intraluminal thrombi/phleboliths (Fig. 2D, N). The lesions were often accompanied by fresh and old hemorrhage with hemosiderin (Fig. 2P) eliciting parenchymal inflammation (Fig. 2O), reactive astrocytosis, gliosis (Fig. 2I, R) and siderotic vessels (Fig. 2G, H), tissue infarction in immediate surrounding parenchyma. The adjacent cortex revealed glial and neuronal changes. Comparison of the findings between the group with and without seizures yielded interesting results, summarized in Table 4.
Interestingly, siderotic vessels in the perilesional tissue was observed exclusively in the cases with seizures (Fig. 2G, H) and absent in those without seizures (0/3 vs. 5/5, p<0.01) (Fig. 2P, Q). Bleed and hemosiderin deposition were common to all cases (Fig. 2P, Q). Perilesional changes like gliosis (Fig. 2I, R), reactive astrocytosis, sclerosis of vessel, inflammation, fibrosis, infarction, calcification (Fig. 2F), and cortical changes like dyslamination/dysmorphic changes in cortical neurons did not show any statistical difference between the two groups.
Fig. 2 angioarchitectural features and changes in perilesional tissue of cerebral CCM with and without seizures on radiology and histomorphology.

Discussion

AVMs are abnormal tangles of dilated vessels (nidus) with arterialized veins and veins of varying thickness and caliber lacking an intervening capillary network, which results in direct shunting of high-pressure arterial system and low pressure venous system.
CCMs are sinusoidal vascular channels devoid of muscular and elastic tissue. They are lined by a single layer of endothelial cells that lack intervening tight junctions.2 Both AVM and CCM present with intracerebral hemorrhage, followed by seizures. Other presentations are non-hemorrhagic including focal neurologic deficits, headache, or maybe asymptomatic and detected on brain imaging performed for other reasons.19 In our study, we analyzed the factors associated with seizure in two of the most common types of CVM-AVM and CCM. Seizure was the presenting complaint in 39% of AVM and 46.6% of CCM compared to 29–36% in other series in published literature.6,7,20 These studies noted higher incidence of seizures in younger age group (21–40 years), compared to focal deficits in those aged 60 years and above, which is similar to our study. In addition, male gender had higher predilection for seizures,6,21 as noted in our study in both AVM and CCM (3:1 and 7:1, respectively).
Previous studies identified cortical, temporal superficial nidus locations, superficial venous drainage, length of leptomeningeal course of draining vein, presence of fistula and venous stenosis as predictors of AVM-associated epilepsy.6,7,9,21,22 Large size of AVM (>3 cm) is an independent predictor of seizure (p<0.0001).6,16 In our study, we included only cortical based cases, most in temporal or frontal location with superficial drainage, with no statistically significant difference in patients with seizures. This could be due to our inclusion criteria of evaluating only lobar lesions. We did not find any correlation between the size of AVM and seizures.
Various factors implicated in epileptogenesis in CVM are haemodynamic changes and the alterations in the adjacent neuroglial parenchyma.23 Brain tissue around the AVM is prone for hypoperfusion, due to arteriovenous shunting called as ‘steal phenomenon’ or due to the loss of autoregulation of cerebral circulation.14 Impaired perinidal cerebrovascular reserve cause hypoperfusion-induced remodeling of the perinidal cortex resulting in chronic ischemia, neoangiogenesis, potentiating neuronal excitatory pathways, favoring an epileptogenic mechanism.16,2426 In our study, the perilesional tissue had higher frequency of hemosiderin deposition and gliosis in the group with seizures. These findings support the hypothesis that in AVM, vascular remodelling, chronic bleed and micro hemorrhages cause hemosiderin deposition in perilesional tissue triggering gliosis, and epileptogenesis. Astrocytes, either through their interaction with excitatory neurotransmitter release or by reducing the antiepileptogenic adenosine content promote epileptogenesis 2730 Dyslamination of neurons and dysmorphic neurons are associated with seizures in the background of cortical dysplasias, trauma, ischemia.31
Distortion of neuronal lamination and dysmorphic neurons in adjacent cortex were seen in AVM, but occurred with equal frequency in both groups.
Intriguingly, in CCM, these same factors did not play a significant role in seizure causation as hemosiderin deposition was seen in all cases of CCM, with and without seizures. On imaging, they showed heterogenous signal intensity with peripheral hemosiderin rim blooming on gradient/SWI images. There was no statistical difference in their appearance between the groups with and without seizures. The thin walled veins tend to be leaky with a propensity to bleed. However, the presence of siderotic vessels in the adjacent cortex was seen only in those cases presenting with seizures. This is a novel finding in the present study. It is tempting to speculate that the iron/calcium deposits in the vessels might be transported from the endothelial cells into the astrocytic foot processes lining these vessels, and the injured astrocyte may in turn disrupt synaptic function, triggering seizure activity.
Recurrent hemorrhage due to leaky endothelial junctions in CCM causing persistent hemosiderin deposition, contributing to chronic cortical irritation and remodeling of the underlying cerebral cortex and gliosis have been implicated in other studies.32,33 However, none of the previous studies have highlighted the presence of siderotic vessels. In CCM, the hemosiderin deposition induces alteration in the physiologic environment surrounding CCM by abrogating glutamate uptake, causing high-amplitude, complex spontaneous synaptic events. This promotes neuronal hypersynchronization and propagating perilesional excitatory stimuli to other cortical regions.34 The leaky endothelial junctions produce elevated concentrations of serine and glycine in the peripheral zones of CCM35 and perilesional albumin leakage that promote hyperexcitability.36
These findings that perilesional tissue with hemosiderin deposits, and gliosis maybe primarily responsible for seizure causation, suggests extended surgical resection to include the perilesional tissue may achieve a more favorable seizure outcome following surgery.16 The finding by Baranoski et al.37 that surgical resection of AVM led to better seizure control and higher rates of seizure-freedom compared to embolization or radiosurgery,38 may be attributable to the removal of perilesional epileptogenic focus, validating our findings in this study.3,39
We conclude that in CMVs, changes in adjacent cortex promote epileptogenisis rather than the malformation per se, specifically reactive gliosis and hemosiderin deposits in AVM and siderotic vessels in CCM. Our study is the first to report this association of siderotic vessels in CCM with seizures. Insights into specific histomorphological feature associated with seizures provides understanding of the role of vascular and stromal factors. Individualized treatment strategies can then be made based on the clinical presentation and angioarchitectural characteristics and perilesional tissue of the CVM. Extended lesionectomy, including the adjacent gliotic epileptogenic cortex can be recommended for optimal surgical outcome and seizure control. These findings need validation in large cohorts.

Acknowledgement

The authors wish to thank Dr. Anandaraj, Assistant Professor, Community Medicine, IGMCRI, Pondicherry for guidance on statistical analysis and Mr. K Manjunath, Department of Neuropathology, NIMHANS, India for assistance with photographic montages.

Figure 1
Angioarchitectural and perilesional tissue alterations in arteriovenous malformation (AVM) with and without seizures. AVM with seizure: angiography images of left internal carotid artery injection show left anterior and mid temporal AVM with feeders from anterior and mid temporal branches of left middle cerebral artery (MCA) and lateral striate vessels. Juxta nidal aneurysm is noted and is draining into left basal vein of Rosenthal. Magnetic resonance imaging fluid attenuated inversion recovery and post-contrast images show hemorrhagic cavity with enhancement of the aneurysm (A–C). Histology reveals conglomerate of arteries and veins of variable thickness (D, E). Perilesional tissue shows prominent hemosiderin deposits (F), highlighted by Perl’s stain (PERL) (F, inset). Adjacent cortex shows mild dyslamination (G) with few dysmorphic neurons (H). Marked reactive gliosis with astrocytosis seen (I). AVM without seizure: T2WI, susceptibility weighted imaging (SWI) and angiogram images show left parietal AVM appearing heterogeneously hyperintense on T2WI (J) with blooming on SWI images (K). The AVM is fed by angular branch of left MCA and draining into basal vein of Rosenthal through inferior parietal vein (L). Histology reveals AVM nidus with admixed thick walled arteries, veins and arterialized veins with increased elastica in medial wall (M, N) perilesional tissue does not reveal hemosiderin deposits (O, inset), mild dyslamination and dysmorphic neurons are seen in the adjacent cortex with mild perilesional gliosis (P–R). MAT, mesenteric adipose tissue; NF, neuro filament; GFAP, glial fibrillary acidic protein; VEG, vascular endothelial growth factor.
jer-22010f1.jpg
Figure 2
Angioarchitectural and perilesional changes in cerebral cavernous malformation with and without seizures. Cerebral cavernous malformation (CCM) with seizure: magnetic resonance images (MRIs) show left frontal lesion appearing heterogeneous hyperintense on T2WI and T1WI and blooming on gradient images (A–C). Note the popcorn like appearance with peripheral hypointense rim (C), histology shows characteristic back to back arranged cavernous venous channels with hemorrhage (D, E) and focal intraluminal dystrophic calcification (F). Striking feature in perilesional tissue is several thin walled siderotic vessels (G), intensely stained with Perl’s stain (PERL) (H) and marked reactive astrocytosis (I). CCM without seizure: MRIs show heterogenous signal intensities on both T1WI and T2WI, with blooming on susceptibility weighted imaging sequences and peripheral hypointense rim in left frontal region (J–L). Histology reveals cavernous malformation composed of thin walled veins with mild sclerosis of wall (M, N). Moderately dense lympho-mononuclear infiltrate in the perilesional zone (O) with numerous hemosiderin laden macrophages due to bleed (P), highlighted on Perl’s prussian blue stain (Q). Note conspicuous absence of siderotic vessels (V). There is moderate perilesional gliosis (R) highlighted by GFAP. MAT, mesenteric adipose tissue; NF, neuro filament; GFAP, glial fibrillary acidic protein; VEG, vascular endothelial growth factor.
jer-22010f2.jpg
Table 1
Comparison of AVM topographic and angioarchitectural features on radiology in patients with and without seizure
Angioarchitecture feature No. of patient (total=21) Without seizure (n=10) With seizure (n=11) p-value
Location 0.12
 Frontal 8 (38.0) 2 (25.0) 6 (75.0)
 Temporal 7 (33.0) 4 (57.0) 3 (43.0)
 Parietal 4 (19.0) 2 (50.0) 2 (50.0)
 Multilobar 2 (10.0) 2 (100.0) 0 (0.0)
Size of nidus 0.66
 Small 6 (28.0) 4 (67.0) 2 (33.0)
 Medium 13 (62.0) 5 (38.0) 8 (62.0)
 Large 2 (10.0) 1 (50.0) 1 (50.0)
Gliosis 18 (86.0) 8 (44.0) 10 (56.0) 0.59
Bleed 15 (71.0) 7 (47.0) 8 (53.0) 1.00
Hemosiderin rim 14 (67.0) 6 (43.0) 8 (57.0) 0.66
Intranidal aneurysm 5 (29.0) 4 (80.0) 1 (20.0) 0.15
Intranidal fistula 7 (33.0) 4 (57.0) 3 (43.0) 0.66
No. of feeder artery 0.66
 Single 8 (38.0) 3 (37.0) 5 (63.0)
 Multiple 13 (62.0) 7 (54.0) 6 (46.0)
Feeder artery hypertrophy 20 (95.0) 9 (45.0) 11(55.0) 0.48
Feeder artery aneurysm 3 (14.0) 1 (33.0) 2 (67.0) 1.00
Steal 10 (48.0) 5 (50.0) 5 (50.0) 1.00
Number of veins 0.39
 Single 12 (57.0) 7 (58.0) 5 (42.0)
 Multiple 9 (43.0) 3 (33.0) 6 (67.0)
Venous drainage topography 1.00
 Superficial 19 (90.0) 9 (47.0) 10 (53.0)
 Deep 2 (10.0) 1 (50.0) 1 (50.0)
Length of leptomeningeal course of the vein 1.00
 Short 3 (14.0) 1 (33.0) 2 (67.0)
 Medium 9 (43.0) 5 (55.0) 4 (45.0)
 Long 9 (43.0) 4 (45.0) 5 (55.0)
Dilatation of vein 9 (43.0) 3 (33.0) 6 (67.0) 0.39
Stenosis of draining vein 8 (38.0) 4 (50.0) 4 (50.0) 1.00

Values are presented as number (%).

AVM, arteriovenous malformation.

Table 2
Comparison of AVM histomorphological features in patients with and without seizures
Histomorphologic feature Number of patient (total=24) AVM without seizure (n=12) With seizure (n=12) p-value
Bleed 10 (42.0) 3 (30.0) 7 (70.0) 0.098
Gliosis 12 (50.0) 1 (8.0) 11 (92.0) <0.001
Hemosiderin deposits 8 (33.0) 0 (0.0) 8 (100.0) 0.001
Inflammation 7 (29.0) 2 (28.0) 5 (72.0) 0.371
Calcification 4 (17.0) 2 (50.0) 2 (50.0) 1.000
Sclerosis of vessels 20 (83.0) 10 (50.0) 10 (50.0) 1.000
Fibrosis of stroma 3 (12.0) 1 (33.0) 2 (67.0) 1.000
Thrombosis 2 (8.0) 1 (50.0) 1 (50.0) 1.000
Predominant portion of AVM 1.000
 Arterialised vein 10 (42.0) 5 (50.0) 5 (50.0)
 Vein 14 (58.0) 7 (50.0) 7 (50.0)
Infarction 7 (29.0) 3 (43.0) 4 (57.0) 1.000
Dyslamination of neurons 8 (33.0) 4 (50.0) 4 (50.0) 1.000
Dysmorphic neurons 2 (8.0) 1 (50.0) 1 (50.0) 1.000

Values are presented as number (%).

AVM, arteriovenous malformation.

Table 3
Comparison of CCM topographic and angioarchitectural features in patients with and without seizure presentation
Angioarchitectural feature No. of patient (total=8) Without seizure (n=3) With seizure (n=5) p-value
Size 1.000
 <3 cm 4 (50.0) 1 (25.0) 3 (75.0)
 >3 cm 4 (50.0) 2 (50.0) 2 (50.0)
Location 0.464
 Frontal 5 (62.0) 1 (20.0) 4 (80.0)
 Temporal 3 (37.0) 2 (67.0) 1 (33.0)
Contrast enhancement 3 (37.0) 1 (33.0) 2 (67.0) 1.000
Zabramski classification type 0.107
 I 2 (25.0) 2 (100.0) 0 (0.0)
 II 5 (62.0) 1 (20.0) 4 (80.0)
 III 1 (12.0) 0 (0.0) 1 (100.0)
Perilesional hypointensity 7 (87.0) 3 (43.0) 4 (57.0) 1.000
Gliosis 7 (87.0) 3 (43.0) 4 (57.0) 1.000
Multiplicity 1.000
 Single 4 (50.0) 2 (50.0) 2 (50.0)
 Multiple 4 (50.0) 1 (25.0) 3 (75.0)

Values are presented as number (%).

CCM, cerebral cavernous malformation.

Table 4
Comparison of CCM histomorphological features in patients with and without seizure presentation
Histomorhologic feature Number present (total=8) Without seizure (n=3) With seizure (n=5) p-value
Gliosis 7 (87.0) 2 (28.0) 5 (72.0) 0.375
Reactive astrocytosis 6 (75.0) 3 (50.0) 3 (50.0) 0.464
Siderotic vessels 5 (62.0) 0 (0.0) 5 (100.0) 0.018
Inflammation 4 (50.0) 3 (75.0) 1 (25.0) 0.143
Calcification 5 (62.0) 1 (20.0) 4 (80.0) 0.464
Sclerosis of vessels 7 (87.0) 2 (28.0) 5 (72.0) 0.375
Fibrosis of stroma 5 (62.0) 2 (40.0) 3 (60.0) 1.000
Dyslamination of neurons 4 (50.0) 2 (50.0) 2 (50.0) 1.000
Dysmorphic neurons 3 (37.0) 1 (33.0) 2 (67.0) 1.000

Values are presented as number (%).

CCM, cerebral cavernous malformation.

References

1. Challa VR, Moody DM, Brown WR. Vascular malformations of the central nervous system. J Neuropathol Exp Neurol. 1995;54:609–1.

2. Josephson CB, Rosenow F, Al-Shahi Salman R. Intracranial vascular malformations and epilepsy. Semin Neurol. 2015;35:223–34.

3. Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2011;76:1548–54.

4. Ding D, Starke RM, Quigg M, et al. Cerebral arteriovenous malformations and epilepsy, part 1: predictors of seizure presentation. World Neurosurg. 2015;84:645–52.

5. Jones JE, Berven NL, Ramirez L, Woodard A, Hermann BP. Long-term psychosocial outcomes of anterior temporal lobectomy. Epilepsia. 2002;43:896–903.

6. Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy CS. Results of multi-modality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery. 2002;51:303–9. discussion 309–11..

7. Galletti F, Costa C, Cupini LM, et al. Brain arteriovenous malformations and seizures: an Italian study. J Neurol Neurosurg Psychiatry. 2014;85:284–8.

8. Jiang P, Lv X, Wu Z, et al. Characteristics of brain arteriovenous malformations presenting with seizures without acute or remote hemorrhage. Neuroradiol J. 2011;24:886–8.

9. Turjman F, Massoud TF, Sayre JW, Viñuela F, Guglielmi G, Duckwiler G. Epilepsy associated with cerebral arteriovenous malformations: a multi-variate analysis of angioarchitectural characteristics. AJNR Am J Neuroradiol. 1995;16:345–50.

10. Menzler K, Chen X, Thiel P, et al. Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery. 2010;67:918–24.

11. Robinson JR, Awad IA, Magdinec M, Paranandi L. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993;32:730–5. discussion 735–6..

12. Moriarity JL, Wetzel M, Clatterbuck RE, et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery. 1999;44:1166–71. discussion 1172–3..

13. Casazza M, Broggi G, Franzini A, et al. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery. 1996;39:26–32. discussion 32–4..

14. Moftakhar P, Hauptman JS, Malkasian D, Martin NA. Cerebral arteriovenous malformations. Part 2: physiology. Neurosurg Focus. 2009;26:E11

15. Crawford PM, West CR, Shaw MD, Chadwick DW. Cerebral arteriovenous malformations and epilepsy: factors in the development of epilepsy. Epilepsia. 1986;27:270–5.

16. Fierstra J, Conklin J, Krings T, et al. Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain. 2011;134:100–9.

17. Lawton MT. Spetzler-martin grade III arteriovenous malformations: surgical results and a modification of the grading scale. Neurosurgery. 2003;52:740–8.

18. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80:422–32.

19. Morris Z, Whiteley WN, Longstreth WT, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016

20. Stapf C, Khaw AV, Sciacca RR, et al. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke. 2003;34:2664–9.

21. Garcin B, Houdart E, Porcher R, et al. Epileptic seizures at initial presentation in patients with brain arteriovenous malformation. Neurology. 2012;78:626–31.

22. Shankar JJ, Menezes RJ, Pohlmann-Eden B, Wallace C, terBrugge K, Krings T. Angioarchitecture of brain AVM determines the presentation with seizures: proposed scoring system. AJNR Am J Neuroradiol. 2013;34:1028–34.

23. Kraemer DL, Awad IA. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia. 1994;35:Suppl 6. S30–43.

24. Herzig R, Bogousslavsky J, Maeder P, et al. Intracranial arterial and arteriovenous malformations presenting with infarction. Lausanne stroke registry study. Eur J Neurol. 2005;12:93–102.

25. Zschocke S. Pathogenesis of epileptic seizures in patients with cerebral arteriovenous angioma. The role of cerebral ischemia (author’s transl). Fortschr Neurol Psychiatr Grenzgeb. 1974;42:433–53.

26. Ndode-Ekane XE, Hayward N, Gröhn O, Pitkänen A. Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience. 2010;166:312–32.

27. Seifert G, Schilling K, Steinhäuser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci. 2006;7:194–206.

28. Fedele DE, Gouder N, Güttinger M, et al. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain. 2005;128:Pt 10. 2383–95.

29. de Lanerolle NC, Lee TS, Spencer DD. Astrocytes and epilepsy. Neurotherapeutics. 2010;7:424–38.

30. Coulter DA, Steinhäuser C. Role of astrocytes in epilepsy. Cold Spring Harb Perspect Med. 2015;5:a022434

31. Bae YS, Kang HC, Kim HD, Kim SH. New classification of focal cortical dysplasia: application to practical diagnosis. J Epilepsy Res. 2012;2:38–42.

32. Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006;21:e7

33. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71:188–92.

34. Williamson A, Patrylo PR, Lee S, Spencer DD. Physiology of human cortical neurons adjacent to cavernous malformations and tumors. Epilepsia. 2003;44:1413–9.

35. von Essen C, Rydenhag B, Nyström B, Mozzi R, van Gelder N, Hamberger A. High levels of glycine and serine as a cause of the seizure symptoms of cavernous angiomas? J Neurochem. 1996;67:260–4.

36. Seiffert E, Dreier JP, Ivens S, et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci. 2004;24:7829–36.

37. Baranoski JF, Grant RA, Hirsch LJ, et al. Seizure control for intracranial arteriovenous malformations is directly related to treatment modality: a meta-analysis. J Neurointerv Surg. 2014;6:684–90.

38. Wang JY, Yang W, Ye X, et al. Impact on seizure control of surgical resection or radiosurgery for cerebral arteriovenous malformations. Neurosurgery. 2013;73:648–55. discussion 655–6..

39. Josephson CB, Bhattacharya JJ, Counsell CE, et al. Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology. 2012;79:500–7.

TOOLS
PDF Links  PDF Links
PubReader  PubReader
XML Download  XML Download
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplement  Supplement
  Print
Share:      
METRICS
0
Crossref
471
View
0
Download
Editorial Office
KCC Parktown 101-308, Mallijae-ro 185, Jung-Gu, Seoul, Korea
TEL : +82-2072-2237   FAX : +82-2-362-9663   E-mail : 40403@snuh.org

Copyright© Korean Epilepsy Society.              Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers